Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date
2853 results found
2025 ∙ Yappalparvi, A. Khatib, M. N. Balaraman, A. K. Rekha, M. M. Kaur, M. Sharma, G. C. Sudan, P. Naidu, K. S. Singh, R. Ramashankar, S. Khati, K. Chauhan, S. S. Verma, L. Sidhu, A. Mehta, R. Sah, R. Gaidhane, A. M. Shabil, M. Chipeta, J. C. Bushi, G.
Prevalence of Mpox vaccine acceptance and hesitancy among people living with HIV: a comprehensive systematic review and meta-analysis
All age groups Mpox Acceptance
Rating:
Not applicable
2025 ∙ Trusinska, D. Lee, B. Ferdous, S. Kwok, H. H. Y. Gordon, B. Gao, J. Ma, L. Xiong, H. Sheikh, S. A. Schwarze, J. Busby, J. Gibbons, C. Drysdale, S. B. Ritchie, S. L. Williams, T. Shi, T.
Real-world uptake of nirsevimab, RSV maternal vaccine, and RSV vaccines for older adults: a systematic review and meta-analysis
Newborn Children Adults Older adults Pregnant women RSV (Respiratory syncytial virus) Coverage
Rating:
Not applicable
2025 ∙ Askar, M. Ali, K. A. Batke, M. Brugger, T. Falman, A. Robertson, A. H. Perez, J. J. Johansen, K. de Jonge, J. Krause, T. G. Kulper-Schiek, W. Meerpohl, J. J. Melidou, A. Nohynek, H. Olmedo, C. Olsson, K. Pavlopoulou, I. Piechotta, V. Rubin, J. Schlaberg, J. Schmucker, C. Siemens, W. Stratil, J. Ucakar, V. Wichmann, O. Harder, T.
Relative Efficacy, Effectiveness and Safety of Newer and/or Enhanced Seasonal Influenza Vaccines for the Prevention of Laboratory-Confirmed Influenza in Individuals Aged 18 years and Over: Update of a Systematic Review
Adults Older adults Influenza Efficacy/effectiveness Safety
Rating:
High
2025 ∙ Kolsuz, S. Gullu, D. Karahan, K. D. Ergonul, O.
Risk factors and preventive role of vaccination in adult tetanus fatality: a systematic review of reported cases (1990-2024) and meta-analysis
Adults Older adults Tetanus Efficacy/effectiveness
Rating:
Critically low
2025 ∙ Ugwu, C. L. J. Bragazzi, N. L. Wu, J. Kong, J. D. Asgary, A. Orbinski, J. Woldegerima, W. A.
Risk factors associated with human Mpox infection: A systematic review and meta-Analysis
All age groups Mpox Efficacy/effectiveness
Rating:
Low
2025 ∙ Kosmeri, C. Klapas, A. Evripidou, N. Kantza, E. Serbis, A. Siomou, E. Ladomenou, F.
Rotavirus Vaccination Protects Against Diabetes Mellitus Type 1 in Children in Developed Countries: A Systematic Review and Meta-Analysis
Children Rotavirus Efficacy/effectiveness
Rating:
Critically low
2025 ∙ Tahrat, H. Munir, A. Marchetti, F.
Rotavirus vaccine coverage, completion, and compliance: A systematic literature review
Newborn Children Rotavirus Coverage
Rating:
Not applicable
2025 ∙ Larney, C. Foley, P. Daniel, B. S.
Safety and Immunogenicity of Live Attenuated Vaccine Administration in Patients Undergoing Treatment With Dupilumab and Apremilast: A Systematic Review
Adults Safety Efficacy/effectiveness
Rating:
Critically low
2025 ∙ Bandell, A. Giles, L. Cervelo Bouzo, P. Sibbring, G. C. Maniaci, J. Wojtczak, H. Sokolow, A.
Safety of LAIV Vaccination in Asthma or Wheeze: A Systematic Review and GRADE Assessment
Children Adolescents Adults Influenza Safety
Rating:
Critically low
2025 ∙ Chiavarini, M. Genga, A. Ricciotti, G. M. D'Errico, M. M. Barbadoro, P.
Safety, Immunogenicity, and Efficacy of Cytomegalovirus Vaccines: A Systematic Review of Randomized Controlled Trials
All age groups Cytomegalovirus Safety Efficacy/effectiveness
Rating:
Critically low
Loading...